Clinica    Scrip    Scrip Regulatory Affairs    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Forgotten password?
Sign me in automatically next time
Home
Market Sector
Business
Policy & Regulation
Regions
IVDs
|
Imaging & IT
|
Cardiovascular
|
Orthopaedics
|
Surgical & Wound care
|
Cellular & Genetic
|
Neurological
|
Other
|
clinica
Market Sector - Orthopaedics
S&N's cost-cutting efforts hike up Q4 trading margin
02 February 2012
Smith & Nephew beat its trading profit margin target in the fourth quarter of 2011, thanks largely to the company's efforts to curb costs and create a more streamlined organisation. The firm reported trading profit of $279m in Q4, on the back of a ...
PIP breast implants sold in 71 countries, not 66, according to French report
02 February 2012
The French government has published a comprehensive report on the history, current situation and implications of the crisis involving fraudulent silicone breast implants made by the now-defunct Poly Implant Protheses (PIP). Among the most ...
BioMimetic's star continues to fall as it cuts 25% workforce
30 January 2012
BioMimetic Therapeutics has slashed 25% of its workforce, or around 20 employees, as it seeks to curb expenditure after approval of its Augment bone graft was delayed. Earlier this month the US FDA rejected the firm's premarket approval (PMA) ...
More hip trouble on horizon for DePuy as Pinnacle Ultamet patient sues?
24 January 2012
Johnson & Johnson subsidiary DePuy Orthopaedics may be facing more problems with its metal-on-metal (MoM) hip implants, after a patient receiving its Pinnacle Ultamet device sued the company. DePuy told Clinica that it "stands firmly behind the ...
Stryker pays $15m to settle OP-1 spinal implant fraud allegations
20 January 2012
Stryker has agreed to pay $15m to settle an investigation over claims its biotech business fraudulently marketed its OP-1 spinal implant and bone putty, and submitted false reports to the US FDA . As part of the agreement, Stryker Biotech will also ...
 
Osiris receives first payments from NuVasive deal
12 January 2009
Osiris Therapeutics has gained a $5m milestone payment after hitting the first production target of a supply agreement it has with NuVasive for a bone matrix product (BMP). This pact stems from Osiris’ sale of its Osteocel BMP to NuVasive in July ...
 
Clinica 100: Stryker sets the pace for acquisitions in 2011
01 December 2011
Orthopaedic firm Stryker has been among the more acquisitive companies over the past 18 months, sealing six M&A deals during this period. Madeleine Armstrong spoke to Katherine Owen, vice-president of strategy and investor relations, about the ...
Out of joint: Japan must nurture markets for innovative technologies
23 June 2011
Japan w ants to develop its medtech industry. So how well does it support the technologies in which it already has a stake? If one was look into the field of joint navigation for an answer, they would find that the response is “Not very well”, ...
Moving on up: how ex-Corin chair Peter Gibson is expediting growth at Orthos 27 April 2011

Orthopaedic industry strategist Peter Gibson thought his frontline corporate development days were behind him when he stepped down as Corin chairman in 2003. But retirement turned out to be merely a break. Now chairing orthobiologics manufacturer ...

 
 
COMPANY/ORGANISATION


Loading COMPANY/ORGANISATION ....
 
CONDITION


Loading CONDITION ....
 
GEOGRAPHY


Loading GEOGRAPHY ....
 
MEDICAL TECHNOLOGY


Loading MEDICAL TECHNOLOGY ....
 
EVENTS
The 14th MedTech Investing Europe conference
19 March 2012
Montreux Convention and Music Centre, Switzerland
HTAi 2012
23 June 2012
Bilbao, Spain
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Clinica
Scrip
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm